Lipid Sciences, Inc. (Nasdaq: LIPD) today presented new anti-inflammatory data supporting the Company's HDL Mimetic Peptide development program at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE